Capture.JPG

2018 New Drug Approvals

  • Rare Diseases: 34 novel approvals including treatments for of rickets, Fabry disease, phenylketonuria
  • Infectious Diseases: Notables include treatments for smallpox, malaria, HIV-1, nontuberculous mycobacterial lung disease
  • Neurological Disorders: Notables include treatment for seizures in Lennox-Gastaut syndrome and Dravet syndrome, migraine, polyneuropathy in hereditary transthyretin-mediated amyloidosis, multiple sclerosis in children
  • Heart, Lung, and Circulatory Diseases: Notable include treatment of hereditary angioedema
  • Women’s Health:  First new treatment for endometriosis pain,  first vaginal ring contraceptive for use for an entire year
  • Cancer and Blood Disorders: New advances for breast cancer, prostate cancer, lung cancer, melanoma, cancer in pancreas or gastrointestinal tract, first treatment  for pheochromocytoma or paraganglioma, new cancer therapy to treat any tumor with specific genetic marker, acute myeloid leukemia, classical Hodgkin lymphoma, acute lymphoblastic leukemia, mycosis fungoides or Sézary syndrome,  thrombocytopenia
  • Other: Non-opioid drug product  for opioid withdrawal symptoms, non-opioid nerve block therapy,  ulcerative colitis, neurotrophic keratitis, seven new biosimilars

Capture.JPG

LEARN

 

Advertisements